Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: To report a case of proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. Methods: We describe the clinical history, physical examination findings, and laboratory values of the patient and briefly review the relevant literature. Results: A 48-year-old woman with a history of postsurgical hypoparathyroidism who was taking calcium carbonate, 1500 mg 3 times daily, and cholecalciferol, 1200 IU daily, presented with a generalized seizure in the setting of hypocalcemia 12 days after initiating therapy with the proton pump inhibitor lansoprazole. Physical examination revealed a positive Chvostek sign. Electrocardiogram was notable for a prolonged QTc interval of 576 milliseconds. Laboratory data were notable for the following values: total serum calcium, 5.3 mg/dL; ionized calcium, 2.51 mg/dL; and intact parathyroid hormone, 5.8 pg/mL. The patient's condition responded to therapy with intravenous calcium gluconate, oral calcium carbonate, and calcitriol. As an outpatient she remained asymptomatic off lansoprazole, treated with calcium carbonate and calcitriol. Conclusions: Caution should be exercised in prescribing proton pump inhibitors to patients with a history of hypoparathyroidism treated with calcium carbonate supplementation because severe hypocalcemia is a potential adverse effect.

Original languageEnglish (US)
Pages (from-to)104-107
Number of pages4
JournalEndocrine Practice
Volume17
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Hypoparathyroidism
Calcium Carbonate
Proton Pump Inhibitors
Seizures
Lansoprazole
Hypocalcemia
Calcitriol
Physical Examination
Calcium Gluconate
Calcium
Cholecalciferol
Parathyroid Hormone
Electrocardiography
Outpatients
Therapeutics
Serum

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. / Milman, Sofiya; Epstein, Eric J.

In: Endocrine Practice, Vol. 17, No. 1, 01.2011, p. 104-107.

Research output: Contribution to journalArticle

@article{8f8058717ebe48029ba19ec95044ac05,
title = "Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism",
abstract = "Objective: To report a case of proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. Methods: We describe the clinical history, physical examination findings, and laboratory values of the patient and briefly review the relevant literature. Results: A 48-year-old woman with a history of postsurgical hypoparathyroidism who was taking calcium carbonate, 1500 mg 3 times daily, and cholecalciferol, 1200 IU daily, presented with a generalized seizure in the setting of hypocalcemia 12 days after initiating therapy with the proton pump inhibitor lansoprazole. Physical examination revealed a positive Chvostek sign. Electrocardiogram was notable for a prolonged QTc interval of 576 milliseconds. Laboratory data were notable for the following values: total serum calcium, 5.3 mg/dL; ionized calcium, 2.51 mg/dL; and intact parathyroid hormone, 5.8 pg/mL. The patient's condition responded to therapy with intravenous calcium gluconate, oral calcium carbonate, and calcitriol. As an outpatient she remained asymptomatic off lansoprazole, treated with calcium carbonate and calcitriol. Conclusions: Caution should be exercised in prescribing proton pump inhibitors to patients with a history of hypoparathyroidism treated with calcium carbonate supplementation because severe hypocalcemia is a potential adverse effect.",
author = "Sofiya Milman and Epstein, {Eric J.}",
year = "2011",
month = "1",
doi = "10.4158/EP10241.CR",
language = "English (US)",
volume = "17",
pages = "104--107",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "1",

}

TY - JOUR

T1 - Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism

AU - Milman, Sofiya

AU - Epstein, Eric J.

PY - 2011/1

Y1 - 2011/1

N2 - Objective: To report a case of proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. Methods: We describe the clinical history, physical examination findings, and laboratory values of the patient and briefly review the relevant literature. Results: A 48-year-old woman with a history of postsurgical hypoparathyroidism who was taking calcium carbonate, 1500 mg 3 times daily, and cholecalciferol, 1200 IU daily, presented with a generalized seizure in the setting of hypocalcemia 12 days after initiating therapy with the proton pump inhibitor lansoprazole. Physical examination revealed a positive Chvostek sign. Electrocardiogram was notable for a prolonged QTc interval of 576 milliseconds. Laboratory data were notable for the following values: total serum calcium, 5.3 mg/dL; ionized calcium, 2.51 mg/dL; and intact parathyroid hormone, 5.8 pg/mL. The patient's condition responded to therapy with intravenous calcium gluconate, oral calcium carbonate, and calcitriol. As an outpatient she remained asymptomatic off lansoprazole, treated with calcium carbonate and calcitriol. Conclusions: Caution should be exercised in prescribing proton pump inhibitors to patients with a history of hypoparathyroidism treated with calcium carbonate supplementation because severe hypocalcemia is a potential adverse effect.

AB - Objective: To report a case of proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. Methods: We describe the clinical history, physical examination findings, and laboratory values of the patient and briefly review the relevant literature. Results: A 48-year-old woman with a history of postsurgical hypoparathyroidism who was taking calcium carbonate, 1500 mg 3 times daily, and cholecalciferol, 1200 IU daily, presented with a generalized seizure in the setting of hypocalcemia 12 days after initiating therapy with the proton pump inhibitor lansoprazole. Physical examination revealed a positive Chvostek sign. Electrocardiogram was notable for a prolonged QTc interval of 576 milliseconds. Laboratory data were notable for the following values: total serum calcium, 5.3 mg/dL; ionized calcium, 2.51 mg/dL; and intact parathyroid hormone, 5.8 pg/mL. The patient's condition responded to therapy with intravenous calcium gluconate, oral calcium carbonate, and calcitriol. As an outpatient she remained asymptomatic off lansoprazole, treated with calcium carbonate and calcitriol. Conclusions: Caution should be exercised in prescribing proton pump inhibitors to patients with a history of hypoparathyroidism treated with calcium carbonate supplementation because severe hypocalcemia is a potential adverse effect.

UR - http://www.scopus.com/inward/record.url?scp=79952389059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952389059&partnerID=8YFLogxK

U2 - 10.4158/EP10241.CR

DO - 10.4158/EP10241.CR

M3 - Article

C2 - 21041166

AN - SCOPUS:79952389059

VL - 17

SP - 104

EP - 107

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 1

ER -